Eye cancer services at UCLA are offered through the Jules Stein Eye Institute. Clinical activities of the Institute are administered jointly by the UCLA Health Systems Department of Ophthalmology and the UCLA Medical Center.
Clinical care services are provided through two adjacent locations: The Jules Stein Eye Institute and the Doris Stein Eye Research Center. The Institute records more than 80,000 patient visits each year from patients with all categories of eye disorders and visual system diseases. Nationally and internationally renowned faculty representing every ophthalmic specialty are available for consultation, specialized testing and treatment, including tertiary care.
Make a Referral
Our partnership with health professionals in the community is key to our success at UCLA Health System. It is our goal to assist you with referring a patient to UCLA and getting access to our continuing medical education program.
Registered nurses and referral coordinators are available to assist referring physicians and case managers access services at UCLA Health System through the toll-free UCLA Physician Referral Service phone line (1-800-UCLA-MD1). Or, send an email to firstname.lastname@example.org and one of our referral nurses will respond.
Referrals may also be made directly to the Jules Stein Eye Institute:
The Ophthalmology Referral Service (ORS) is a valuable resource for healthcare professionals who want to refer patients and obtain information about the clinical activities at the Jules Stein Eye Institute. Experienced staff are available to answer questions and identify the specific resource needed. ORS has a dedicated telephone line for referring physicians to facilitate prompt access to services.
Physician’s Referral Line
Jules Stein Eye Institute
100 Stein Plaza, UCLA
Los Angeles, CA 90095-7000
For directions, click for our location map.
Currently, over thirty separate studies at the Jules Stein Eye Institute are classified as patient-based or clinical research. These studies often represent the final stages of research prior to dissemination to the ophthalmology community for use with the general population. All studies have been reviewed and approved by the Federal Drug Administration and the UCLA Human Subject Protection Committee.
If you are interested in finding out more about these research studies or to refer a patient, visit our Clinical Trials Guide for a listing of currently open clinical trials.
Learn more about eye cancer services at UCLA by visiting the following related website: